Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AGTR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GABRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF259P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TMEM151A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENPP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ID4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADRA1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00564 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on